View the official press release distributed through PR Newswire.
The emerging leader in liquid biopsy sample prep to showcase new instruments and kits at its conference booth and share advancements in liquid biopsy assays through three poster presentations.
SAN DIEGO, February 20, 2024 – nRichDX®, best known for the development of its Revolution Sample Prep System™, will be introducing new products, presenting new data, and exhibiting at the American Association for Cancer Research (AACR) 2024 Annual Meeting.
Held April 5-10 at the San Diego Convention Center, the conference is dedicated to exploring and recognizing the latest discoveries in cancer research.
nRichDX will exhibit in booth #3721, just inside the main registration entrance, and co-present three posters on April 8 and 9. Exhibits open at 1:00 PM on Sunday, April 7 and close at 12:30 PM on Wednesday, April 10.
New Products and Collaborative Research
New automation, expanded sample capacity, and three scientific poster presentations.
Visit nRichDX at booth #3721
Debut of the Revolution Pro™ high-throughput automated instrument
Introduction of the Revolution Plus™ sample preparation instrument
Three collaborative liquid biopsy research posters
Increasing Analyte Yield for Sensitive Assays
AACR 2024 attendees considering liquid biopsy assays and the extraction of cfDNA, cfRNA, circulating cell-free total nucleic acid (cfTNA), or the enrichment of circulating tumor cells (CTCs), were encouraged to visit the nRichDX booth to see the latest liquid biopsy sample prep solutions.
nRichDX highlighted how extracting higher yields of these analytes can increase assay performance through improved sensitivity and earlier detection of targeted oncology markers.
“nRichDX is setting the standard for liquid biopsy sample preparation with solutions engineered to deliver the highest yield of rare analytes. Higher yields mean greater assay sensitivity and earlier detection.”
“nRichDX is proud to introduce the next generation of Revolution Sample Prep Instruments and Kits at this year’s AACR Annual Meeting,” Curtis said.
Revolution Pro™, Revolution Plus™, and New nRicher™ Cartridges
nRichDX is introducing two new Revolution System instruments at AACR 2024: the Revolution Pro™, a new high-throughput automated instrument, and the Revolution Plus™, a new semi-manual instrument.
nRichDX is also introducing two new nRicher™ Cartridges, designed for easier use and featuring upgraded input sample capacities of 40 mL and 100 mL to maximize rare analyte yield from larger-volume samples such as urine, plasma, and other biofluids.
The new nRicher Cartridges have the broadest sample input volume range of any commercially available kit, from as little as 1 mL up to 100 mL in a single extraction, eliminating yield-lowering sample or eluate pooling and sample transfer steps required by other sample prep methods, especially at sample volumes above 4 mL.
Explore the Revolution PlatformThree Collaborative Posters at AACR 2024
The company is also co-presenting three posters at the meeting featuring the Revolution Sample Prep System for liquid biopsy applications:
April 8, 9:00 AM-12:30 PM:
Enhancing urine-based cfDNA detection for prostate
cancer diagnosis through increased urine input volume
,
presented in collaboration with Agilent Technologies
April 9, 9:00 AM-12:30 PM:
Urine as a non-invasive proxy for plasma in prostate
cancer-related liquid biopsy applications
,
presented in collaboration with OraSure Technologies’
Novosanis Division
April 9, 9:00 AM-12:30 PM:
Achieving sensitivity of 0.1% variant allele frequency
(VAF) in plasma and urine with the nRichDX Revolution
Sample Prep System evaluated on the MassARRAY system
,
presented in collaboration with Agena Bioscience
About nRichDX
nRichDX® provides instruments and kits for the isolation of cfDNA, cfRNA, and the enrichment of CTCs. The patented Revolution Sample Prep System™ is engineered specifically for liquid biopsy applications.
It is the first and only high-yield, high-recovery, IVD-labeled sample prep platform that can process from 1 mL to 50 mL or more of plasma or urine sample volumes in a single extraction using the company’s patented nRicher™ Cartridges.
Unlike other methods, Revolution sample prep doesn’t require yield-lowering eluate pooling or sample transfer steps. nRichDX helps solve one of precision medicine’s greatest problems: inaccurate or incomplete diagnostic results for liquid biopsy-based applications due to insufficient analyte.
Learn more about nRichDX